Studies On Competition And Antitrust Issues In The Pharmaceutical Industry

Author : Ann-Kathrin Lehnhausen
Publisher : Springer
Page : 85 pages
File Size : 40,9 Mb
Release : 2016-11-14
Category : Business & Economics
ISBN : 9783658165512

Get Book

Studies on Competition and Antitrust Issues in the Pharmaceutical Industry by Ann-Kathrin Lehnhausen Pdf

This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-delay strategies, market foreclosure, resale price maintenance, but also mergers and acquisitions, while taking into account market specificities such as the unique research and development process. The study explains why drug prices sometimes remain at elevated levels even after the drug’s patent protection has expired. Knowing the characteristics of such anticompetitive strategies helps customers such as health insurance companies to develop effective counter-strategies.

Author : Pierre Kobel,Pranvera Këllezi,Bruce Kilpatrick
Publisher : Springer
Page : 497 pages
File Size : 48,8 Mb
Release : 2017-09-20
Category : Law
ISBN : 9783319558134

Get Book

Antitrust in Pharmaceutical Markets & Geographical Rules of Origin by Pierre Kobel,Pranvera Këllezi,Bruce Kilpatrick Pdf

This book gathers international and national reports from across the globe on key questions in the field of antitrust and intellectual property. The first part discusses the application of competition law in the pharmaceutical sector, which continues to be a focus for anti-trust authorities around the world. A detailed international report explores the extent to which the application of the competition rules in the pharmaceutical sector should be affected by the specific characteristics of those products and markets (including consumer protection rules, the need to promote innovation, the need to protect public budgets, and other public interest considerations). It provides an excellent comparative study of this complex subject, which lies at the interface between competition law and intellectual property law. The second part of the book gathers contributions from various jurisdictions on the topic of “What rules should govern claims by suppliers about the national or geographic origin of their goods or services?” This section presents an international report, which offers an unparalleled comparative analysis of this topic, bringing together common themes and contrasting the various national provisions dealing with indications of origin, amongst other things. The book also includes the resolutions passed by the General Assembly of the International League of Competition Law (LIDC) following a debate on each of these topics, which include proposed solutions and recommendations. The LIDC is a long-standing international association that focuses on the interface between competition law and intellectual property law, including unfair competition issues.

Author : Anonim
Publisher : American Bar Association
Page : 480 pages
File Size : 48,7 Mb
Release : 2009
Category : Antitrust law
ISBN : 1604425628

Get Book

Pharmaceutical Industry Antitrust Handbook by Anonim Pdf

Author : Margherita Colangelo
Publisher : Unknown
Page : 0 pages
File Size : 42,8 Mb
Release : 2023
Category : Antitrust law
ISBN : 1509965548

Get Book

Regulation, Innovation and Competition in Pharmaceutical Markets by Margherita Colangelo Pdf

This book explores the fundamental and inextricable relationship between regulation, intellectual property, competition laws, and public health in prescription drugs markets, examining their interconnections and the delicate balance between the various interests and policy goals at stake. Although pharmaceutical markets are heavily regulated and subject to close antitrust scrutiny, there is a constant requirement for existing rules and policies to tackle a number of persistent, complex issues. The variety of anticompetitive practices occurring in this sector, the worrying rise in drug prices, and major, far-reaching concerns over the accessibility of medicines are sources of frequent controversy in academic and policy debate. Understanding the unique features and dynamics of the pharmaceutical industry requires a tailored and multifaceted approach. The study is enhanced by the adoption of a comparative perspective, tracing convergence and divergence between EU and US systems through the analysis of relevant applicable rules, emblematic case studies, and policy choices. Pursuant to this rigorous approach, the book provides an original and thought-provoking critique of the challenges of regulating pharmaceutical markets.

Author : Pablo Figueroa,Alejandro Guerrero
Publisher : Edward Elgar Publishing
Page : 758 pages
File Size : 44,7 Mb
Release : 2019
Category : Business & Economics
ISBN : 9781785362613

Get Book

EU Law of Competition and Trade in the Pharmaceutical Sector by Pablo Figueroa,Alejandro Guerrero Pdf

This book provides a systematic analysis of the law and practice of EU competition and trade in the pharmaceutical sector. Authored by leading private practitioners, economists, scholars and high-level officials at competition regulators, this work provides valuable insider knowledge on the application of law and policies to the pharmaceutical industry. The work contains extensive commentary on the legislation and the latest case law and administrative precedents in this sector, at both EU and national level, including certain significant jurisdictions (e.g., the US, China). Coverage of various key developments includes the recent pay-for-delay antitrust investigations, the perennial issues around parallel trade, and an examination of mergers among pharmaceutical companies and medical devices manufacturers. In addition to the legal analysis, it offers vital economic and business perspectives to ensure that the reader has the full range of tools with which to prepare for cases and conduct transactions within the pharmaceutical industry.

Author : Meir Statman
Publisher : A E I Press
Page : 106 pages
File Size : 45,8 Mb
Release : 1983
Category : Business & Economics
ISBN : STANFORD:36105037524589

Get Book

Competition in the Pharmaceutical Industry by Meir Statman Pdf

Author : Roy Levy
Publisher : DIANE Publishing
Page : 226 pages
File Size : 44,9 Mb
Release : 1999
Category : Antitrust law
ISBN : 9781428953635

Get Book

The Pharmaceutical Industry by Roy Levy Pdf

Author : Björn Lundqvist,Timo Minssen,Justin Pierce
Publisher : Oxford University Press, USA
Page : 576 pages
File Size : 44,9 Mb
Release : 2031-05-30
Category : Law
ISBN : 0198724829

Get Book

Competition Law and IP Rights in Pharmaceuticals and Biotechnology by Björn Lundqvist,Timo Minssen,Justin Pierce Pdf

A comprehensive analysis of European competition law and intellectual property law issues affecting the pharmaceutical and biotechnology sectors, offering both theoretical and practical perspectives.

Author : Pablo Figueroa (Lawyer),Alejandro Guerrero
Publisher : Unknown
Page : 0 pages
File Size : 54,5 Mb
Release : 2019
Category : Antitrust law
ISBN : 1785362607

Get Book

EU Law of Competition and Trade in the Pharmaceutical Sector by Pablo Figueroa (Lawyer),Alejandro Guerrero Pdf

This book provides a systematic analysis of the law and practice of EU competition/antitrust law and trade regulation in the pharmaceutical sector. Authored by leading private practitioners, economists, scholars and high-profile competition enforcers, this work provides valuable insider knowledge on the application of competition law and policies to the pharmaceutical industry. Key features include: Extensive commentary on the legislation and the latest case law and administrative precedents in the pharmaceutical sector, at both EU and national level Coverage of various key developments including the recent pay-for-delay antitrust investigations, the perennial issues around parallel trade, and an examination of mergers among pharmaceutical companies and medical devices manufacturers In-depth analysis of topics commonly raised in the pharmaceutical sector including: pricing policies, IP life-cycle management, IP licensing and horizontal cooperation agreements Key economic and business perspectives to accompany legal analysis, providing the reader with a rounded view of the subject matter. This book will be a useful resource for lawyers and in-house counsel active in the pharmaceutical sector. The information and analysis provided will prepare readers to take on cases and drive the antitrust review of transactions and agreements within the industry. Researchers, economists and civil servants with an interest in competition law and trade regulation can also benefit from the practical insights provided therein.

Author : Akira Negishi,Masako Wakui,Naoko Mariyama
Publisher : Springer
Page : 0 pages
File Size : 46,5 Mb
Release : 2023-02-10
Category : Law
ISBN : 9811678162

Get Book

Competition Law and Policy in the Japanese Pharmaceutical Sector by Akira Negishi,Masako Wakui,Naoko Mariyama Pdf

This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector. It consists of chapters written and edited by academics who research the industry from various perspectives, including economics, competition law, pharmaceutical regulations, and intellectual property law. Competition policies involving pharmaceutical products attract attention from academics and policymakers worldwide. The pharmaceutical industry is regulated by drug laws that vary from country to country and are affected by differing practices and industrial structures. The book begins by examining drug regulations and trade practices in the industry that are peculiar to Japan and its healthcare system. It then presents the Japanese Antimonopoly Act and cases involving it, and discussions of current competition law issues in the Japanese pharmaceutical industry. The book also discusses innovation and intellectual property and economic analyses of pharmaceutical regulations and drug discovery. The chapters include comparative studies on Japanese regulations vs. those in the European Union and the United States. Japan is one of the biggest pharmaceutical markets in the world. With this in mind, the book provides “one-stop shopping” for anyone interested in pharmaceutical regulations in the country. Covering the basics but extending to in-depth explorations of complex problems, this book appeals not only to students and academics, pharmaceutical companies and regulators, but also to those dealing with real-world policy issues that encompass competition policy, intellectual property, and pharmaceutical regulation. Chapter 11 is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com

Author : Josef Drexl,Nari Lee
Publisher : Edward Elgar Publishing
Page : 347 pages
File Size : 49,7 Mb
Release : 2013-01-01
Category : Law
ISBN : 9780857932464

Get Book

Pharmaceutical Innovation, Competition and Patent Law by Josef Drexl,Nari Lee Pdf

Public health, safety and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals. Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination. The contributors to this book, including academics, judges and practitioners from Europe, the US and Japan, explore to what extent patent strategies and life-cycle management practices take advantage of patent laws and health-care regulation and disrupt the necessary balance between incentives for innovation and access to affordable medicine and health care. Addressing fundamental questions in the field of pharmaceutical innovation, this book will appeal to scholars and practitioners in intellectual property, competition law and life sciences regulation, as well as pharmaceutical companies and regulators.

Author : Anonim
Publisher : U.S. Government Printing Office
Page : 94 pages
File Size : 42,7 Mb
Release : 1998
Category : Business & Economics
ISBN : PURD:32754071785707

Get Book

How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry by Anonim Pdf

Author : Anonim
Publisher : DIANE Publishing
Page : 16 pages
File Size : 52,8 Mb
Release : 2010
Category : Drugs
ISBN : 9781437985535

Get Book

Pay-for-Delay: How Drug Company Pay-Offs Cost Consumers Billions by Anonim Pdf

Author : Jerome Ellig
Publisher : Cambridge University Press
Page : 298 pages
File Size : 40,7 Mb
Release : 2001-04-23
Category : Business & Economics
ISBN : 0521782503

Get Book

Dynamic Competition and Public Policy by Jerome Ellig Pdf

Scholars explore antitrust issues as these relate to dynamic industry competition and public policy.

Author : Matthew J. Kotchen,Tatyana Deryugina,James H. Stock
Publisher : University of Chicago Press
Page : 275 pages
File Size : 51,5 Mb
Release : 2022-01-24
Category : Business & Economics
ISBN : 9780226821740

Get Book

Environmental and Energy Policy and the Economy by Matthew J. Kotchen,Tatyana Deryugina,James H. Stock Pdf

This volume presents six new papers on environmental and energy economics and policy in the United States. Rebecca Davis, J. Scott Holladay, and Charles Sims analyze recent trends in and forecasts of coal-fired power plant retirements with and without new climate policy. Severin Borenstein and James Bushnell examine the efficiency of pricing for electricity, natural gas, and gasoline. James Archsmith, Erich Muehlegger, and David Rapson provide a prospective analysis of future pathways for electric vehicle adoption. Kenneth Gillingham considers the consequences of such pathways for the design of fuel vehicle economy standards. Frank Wolak investigates the long-term resource adequacy in wholesale electricity markets with significant intermittent renewables. Finally, Barbara Annicchiarico, Stefano Carattini, Carolyn Fischer, and Garth Heutel review the state of research on the interactions between business cycles and environmental policy.